News | September 22, 2023
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The market capitalization of the company stood at Rs. 7,000 crore +
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
The partnership acknowledges the increasing mental health challenges faced by students in today's society
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Subscribe To Our Newsletter & Stay Updated
